Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Geriatric MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial.Front Aging Neurosci. 2016; 8: 256
- National Academies of Sciences Engineering and Medicine Leshner A.I. Landis S. Stroud C. Preventing cognitive decline and dementia. National Academies Press, Washington, DC2017
- Amyloid-β plaques enhance Alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.Nat Med. 2018; 24: 29-38
- Alzheimer’s disease and gut microbiota modifications: the long way between preclinical studies and clinical evidence.Pharmacol Res. 2018; 129: 329-336
- Inflammation and Alzheimer’s disease.Neurobiol Aging. 2000; 21: 383-421
- Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly.Neurobiol Aging. 2017; 49: 60-68
- Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease.Acta Neuropathol. 2016; 132: 235-256
- A review: inflammatory process in Alzheimer’s disease, role of cytokines.ScientificWorldJournal. 2012; 2012: 1-15
- Inflamm-aging. An evolutionary perspective on immunosenescence.Ann N Y Acad Sci. 2000; 908: 244-254
- Cytokines in neuroinflammation and Alzheimer’s disease.Curr Drug Targets. 2004; 5: 529-534
- Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.J Gerontol A Biol Sci Med Sci. 2014; 69: S4-S9
- Alzheimer’s disease, neuroprotection, and CNS immunosenescence.Front Pharmacol. 2012; 3: 138
- Human gut microbiota: the links with dementia development.Protein Cell. 2017; 8: 90-102
- Microbiota and aging. A review and commentary.Arch Med Res. 2017; 48: 681-689
- Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer’s disease (AD).J Nat Sci. 2015; 1: e138
- Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease.Nutr Rev. 2016; 74: 624-634
- Mechanisms of molecular mimicry involving the microbiota in neurodegeneration.J Alzheimers Dis. 2015; 45: 349-362
- The role of gut microbiota on insulin resistance.Nutrients. 2013; 5: 829-851
- The role of the gut microbiota in energy metabolism and metabolic disease.Curr Pharm Des. 2009; 15: 1546-1558
- Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota.Sci Rep. 2017; 7 (41802)
- Obesity and aging: consequences for cognition, brain structure, and brain function.Psychosom Med. 2015; 77: 697-709
- The relationship between obesity and cognitive health and decline.Proc Nutr Soc. 2017; 76: 443-454
- Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD.Neurology. 2005; 64: 1032-1039
- Alzheimer’s disease and epigenetic diet.Neurochem Int. 2014; 78: 105-116
- Epigenetic regulation in the pathophysiology of Alzheimer’s disease.Prog Neurobiol. 2010; 90: 498-510
- Nutritional medicine as mainstream in psychiatry.Lancet Psychiatry. 2015; 2: 271-274
- Blood glucose influences memory in young adults and attention.Neuropsychologia. 1994; 32: 595-607
- Hypoglycaemia and cognitive function.Diabetes Obes Metab. 2005; 7: 493-503
- Cognitive dysfunction and diabetes mellitus.Endocr Rev. 2008; 29: 494-511
- Connecting Alzheimer’s disease to diabetes: underlying mechanisms and potential therapeutic targets.Neuropharmacology. 2018; 136: 160-171
- Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study.Neurology. 2012; 79: 1019-1026
- Evidence for brain glucose dysregulation in Alzheimer’s disease.Alzheimers Dement. 2018; 14: 318-329
- Impaired peripheral glucose homeostasis and Alzheimer’s disease.Neuropharmacology. 2018; 136: 172-181
- Cognitive development in children with chronic protein energy malnutrition.Behav Brain Funct. 2008; 4: 31
- Nutrition and the developing brain: nutrient priorities and measurement.Am J Clin Nutr. 2007; 85: 614-620
- Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain.J Nutr. 2007; 137 ([discussion: 1548S]): 1539S-1547S
- High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer’s disease.Aging Cell. 2012; 11: 810-822
- Excitatory amino acids and Alzheimer’s disease.Neurobiol Aging. 1989; 10: 593-602
- Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology.J Psychiatry Neurosci. 2013; 38: 6-23
- Acetyl-l-carnitine improves aged brain function.Geriatr Gerontol Int. 2010; 10: 99-106
- Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats.J Alzheimers Dis. 2010; 19: 735-746
- Acetyl-L-carnitine attenuates homocysteine-induced Alzheimer-like histopathological and behavioral abnormalities.Rejuvenation Res. 2011; 14: 669-679
- Oxidative stress and the pathogenesis of Alzheimer’s disease.Oxid Med Cell Longev. 2013; 2013: 1-10
- Protective effect of N-acetyl-l-cysteine on amyloid β-peptide-induced learning and memory deficits in mice.Brain Res. 2006; 1109: 201-206
- Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive.Proteomics. 2012; 11: 4243-4256
- Fish, docosahexaenoic acid and Alzheimer’s disease.Prog Lipid Res. 2009; 48: 239-256
- Omega-3 fatty acids enhance phagocytosis of Alzheimer’s disease-related amyloid-β42 by human microglia and decrease inflammatory markers.J Alzheimers Dis. 2013; 35: 697-713
- Polyunsaturated fatty acids as antioxidants.Pharmacol Res. 2008; 57: 451-455
- Linking lipids to Alzheimer’s disease: cholesterol and beyond.Nat Rev Neurosci. 2011; 12: 284-296
- Banks WA. Lipids and cognition.J Alzheimers Dis. 2010; 20: 737-747
- Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele.Am J Geriatr Psychiatry. 2008; 16: 781-785
- Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later.Neurology. 2018; 90: e73-e81
- Significance of vitamin A to brain function, behavior and learning.Mol Nutr Food Res. 2010; 54: 489-495
- Differential expression of retinoid receptors in the adult mouse central nervous system.Neuroscience. 1999; 89: 1291-1300
- Vitamin A and Alzheimer’s disease.Geriatr Gerontol Int. 2012; 12: 180-188
- Vitamin B1 (thiamine) and dementia.Ann N Y Acad Sci. 2016; 1: 21-30
- Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer’s mouse model.Neurobiol Aging. 2009; 30: 1587-1600
- Anxiolysis and recognition memory enhancement with long-term supplemental ascorbic acid ( vitamin C ) in normal rats: possible dose dependency and sex differences.Ann Neurosci Psychol. 2015; 2: 1-9
- Ascorbic acid and the brain: rationale for the use against cognitive decline.Nutrients. 2014; 6: 1752-1781
- Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.ACS Chem Neurosci. 2015; 6: 570-581
- The effects of vitamin D on brain development and adult brain function.Mol Cell Endocrinol. 2011; 347: 121-127
- Vitamin D and neurocognitive function.Clin Interv Aging. 2014; 9: 559-568
- Calcium regulation of neural rhythms, memory and Alzheimer’s disease.J Physiol. 2014; 592: 281-293
- Tocopherols and tocotrienols plasma levels are associated with cognitive impairment.Neurobiol Aging. 2012; 33: 2282-2290
- Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change.Am J Clin Nutr. 2005; 81: 508-514
- Vitamin K, an emerging nutrient in brain function.Biofactors. 2012; 38: 151-157
- Vitamins and cognition: what is the evidence?.Drugs. 2011; 71: 1957-1971
- B-vitamins reduce plasma levels of beta amyloid.Neurobiol Aging. 2008; 29: 303-305
- B vitamins and the aging brain.Nutr Rev. 2010; 68: S112-S118
- Effects of vitamin B 12 and folate deficiency on brain development in children.Food Nutr Bull. 2008; 29: S126-S131
- Vitamin B12 inhibits tau fibrillization via binding to cysteine residues of tau.ACS Chem Neurosci. 2017; 8: 2676-2682
- Magnesium status in Alzheimer’s disease: a systematic review.Am J Alzheimers Dis Other Demen. 2015; 31: 208-213
- Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer’s model.PLoS One. 2014; 9: 1-11
- Magnesium modulates amyloid-β protein precursor trafficking and processing.J Alzheimers Dis. 2010; 20: 1091-1106
- Manganese action in brain function.Brain Res Brain Res Rev. 2003; 41: 79-87
- Oxidative neuropathology and putative chemical entities for Alzheimer’s disease: neuroprotective effects of salen-manganese catalytic anti-oxidants.Neurotox Res. 2000; 2: 167-178
- Selenium and brain function: a poorly recognized liaison.Brain Res Brain Res Rev. 2004; 45: 164-178
- Impact of selenium on mood and quality of life: a randomized, controlled trial.Biol Psychiatry. 2006; 59: 147-154
- Elevation of serum copper levels in Alzheimer’s disease.Neurology. 2002; 59: 1153-1161
- Brain iron metabolism.Semin Pediatr Neurol. 2006; 13: 142-148
- The neurophysiology and pathology of brain zinc.J Neurosci. 2011; 31: 16076-16085
- Alzheimer’s disease, beta-amyloid protein and zinc.J Nutr. 2000; 130: 1488S-1492S
- Metal chaperones prevent zinc-mediated cognitive decline.Neurobiol Dis. 2015; 81: 196-202
- The neurobiology of zinc in health and disease.Nat Rev Neurosci. 2005; 6: 449-462
- Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease.Free Radic Biol Med. 2012; 52: 35-45
- Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence.PLoS One. 2014; 9: e105070
- Wine polyphenols: potential agents in neuroprotection.Oxid Med Cell Longev. 2012; 2012: 805762
- Dietary flavonoids: bioavailability, metabolic effects, and safety.Annu Rev Nutr. 2002; 22: 19-34
- A survey of modulation of gut microbiota by dietary polyphenols.Biomed Res Int. 2015; 2015: 1-15
- Nutritional strategies in the management of Alzheimer disease: systematic review with network meta-analysis.J Am Med Dir Assoc. 2017; 18: 897.e13-30
- Dietary patterns and risk of dementia: a systematic review and meta-analysis of cohort studies.Mol Neurobiol. 2016; 53: 6144-6154
- Association of Mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis.J Alzheimers Dis. 2014; 39: 271-282
- Mediterranean diet, cognitive function, and dementia: a systematic review of the evidence.Adv Nutr. 2016; : 889-904
- Dietary patterns in Alzheimer’s disease and cognitive aging.Curr Alzheimer Res. 2011; 8: 510-519
- MIND diet associated with reduced incidence of Alzheimer’s disease.Alzheimers Dement. 2015; 11: 1007-1014
- An exploration of the role of a fish-oriented diet in cognitive decline: a systematic review of the literature.Oncotarget. 2017; 8: 39877-39895
- Low-copper diet as a preventive strategy for Alzheimer’s disease.Neurobiol Aging. 2014; 35: S40-S50
- Nutrition and Alzheimer’s disease: the detrimental role of a high carbohydrate diet.Eur J Intern Med. 2011; 22: 134-140
- Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer’s disease incidence and prevalence.J Alzheimers Dis. 2015; 45: 965-979
- Weight loss in Alzheimer disease.Am J Clin Nutr. 2000; 71: 637S-642S
- Weight loss and undernutrition in community-dwelling patients with Alzheimer’s dementia: from population-based studies to clinical management.Z Gerontol Geriatr. 2015; 48: 318-324
- Nutritional and psycho-functional status in elderly patients with Alzheimer’s disease.J Nutr Health Aging. 2012; 16: 231-236
Article info
Publication history
Published online: August 24, 2018
Footnotes
Disclosure Statement: The authors have nothing to disclose.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
